LINEZOLID

LINEZOLID was reported 30259 times

LINEZOLID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI FACTOR V ANTIBODY 20 0.7143
1 MINIMUM INHIBITORY CONCENTRATION 18 0.5455
2 TOXIC OPTIC NEUROPATHY 106 0.2442
3 MYCOBACTERIAL PERITONITIS 22 0.2316
4 CHOROIDITIS 84 0.2246
5 SIDEROBLASTIC ANAEMIA 26 0.1857
6 GEOTRICHUM INFECTION 37 0.1754
7 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 54 0.1748
8 TRICHOGLOSSIA 65 0.1585
9 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 22 0.1549
10 ALVEOLAR LUNG DISEASE 26 0.1368
11 MYCOBACTERIUM FORTUITUM INFECTION 24 0.1297
12 MYCOBACTERIUM ABSCESSUS INFECTION 91 0.1273
13 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 47 0.1158
14 OPTIC NEUROPATHY 242 0.1143
15 MITOCHONDRIAL TOXICITY 89 0.1084
16 PAPILLITIS 17 0.1012
17 CUTANEOUS MUCORMYCOSIS 16 0.0870
18 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 29 0.0866
19 SKIN CANDIDA 39 0.0747
20 DEHISCENCE 14 0.0741
21 HYPERLACTACIDAEMIA 190 0.0708
22 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 15 0.0679
23 MYCOBACTERIUM CHELONAE INFECTION 50 0.0677
24 ANTIDEPRESSANT DISCONTINUATION SYNDROME 14 0.0667
25 OTOTOXICITY 123 0.0665
26 ACID BASE BALANCE ABNORMAL 14 0.0625
27 CEREBRAL NOCARDIOSIS 14 0.0601
28 MENINGITIS TUBERCULOUS 33 0.0590
29 CARDIAC VALVE VEGETATION 28 0.0576
30 BICYTOPENIA 111 0.0566
31 CNS VENTRICULITIS 18 0.0552
32 PULMONARY MUCORMYCOSIS 29 0.0549
33 DYSBIOSIS 41 0.0499
34 SEROTONIN SYNDROME 958 0.0498
35 PANCREATITIS HAEMORRHAGIC 21 0.0453
36 ENTEROCOCCAL INFECTION 213 0.0440
37 TOXIC NEUROPATHY 17 0.0431
38 NOCARDIOSIS 109 0.0426
39 ENTEROCOCCAL BACTERAEMIA 45 0.0425
40 ENTEROCOCCUS TEST POSITIVE 27 0.0417
41 HERPES ZOSTER MENINGOENCEPHALITIS 15 0.0417
42 PNEUMONIA NECROTISING 26 0.0402
43 ACINETOBACTER INFECTION 41 0.0374
44 PATHOGEN RESISTANCE 331 0.0363
45 PULMONARY NOCARDIOSIS 29 0.0352
46 URINARY TRACT INFECTION ENTEROCOCCAL 32 0.0343
47 SYSTEMIC CANDIDA 85 0.0338
48 PSOAS ABSCESS 21 0.0337
49 SPUTUM CULTURE POSITIVE 27 0.0333
50 LACTIC ACIDOSIS 1040 0.0321
51 HAEMOPERITONEUM 25 0.0312
52 MEDIASTINITIS 18 0.0310
53 DRUG RESISTANCE 779 0.0303
54 DIFFERENTIATION SYNDROME 22 0.0300
55 CORYNEBACTERIUM INFECTION 16 0.0299
56 ENTEROCOCCAL SEPSIS 24 0.0296
57 TOXIC LEUKOENCEPHALOPATHY 21 0.0289
58 SERRATIA INFECTION 21 0.0282
59 DELAYED GRAFT FUNCTION 20 0.0281
60 RECTAL PERFORATION 15 0.0278
61 TOOTH DISCOLOURATION 79 0.0268
62 SCEDOSPORIUM INFECTION 18 0.0255
63 AXONAL NEUROPATHY 22 0.0252
64 BRAIN ABSCESS 63 0.0249
65 PROCALCITONIN INCREASED 28 0.0239
66 MULTIPLE-DRUG RESISTANCE 73 0.0235
67 DIFFUSE ALVEOLAR DAMAGE 27 0.0235
68 MYCOBACTERIUM AVIUM COMPLEX INFECTION 63 0.0234
69 PNEUMONIA STAPHYLOCOCCAL 46 0.0233
70 NUTRITIONAL CONDITION ABNORMAL 16 0.0229
71 HYPERLEUKOCYTOSIS 20 0.0226
72 SYSTEMIC MYCOSIS 26 0.0223
73 KLEBSIELLA INFECTION 112 0.0221
74 EOSINOPHILIC PNEUMONIA 67 0.0212
75 DEAFNESS NEUROSENSORY 69 0.0210
76 PARADOXICAL DRUG REACTION 77 0.0209
77 ELECTROCARDIOGRAM QT PROLONGED 737 0.0205
78 VESTIBULAR DISORDER 25 0.0204
79 EXTRADURAL ABSCESS 16 0.0204
80 OPTIC NEURITIS 185 0.0203
81 TONGUE DISCOLOURATION 89 0.0203
82 BLOOD FIBRINOGEN DECREASED 23 0.0201
83 THROMBOCYTOPENIA 2242 0.0200
84 ATYPICAL MYCOBACTERIAL INFECTION 28 0.0198
85 EOSINOPHILIC PNEUMONIA ACUTE 17 0.0196
86 PSEUDOMONAS TEST POSITIVE 16 0.0195
87 HYPERTRANSAMINASAEMIA 136 0.0195
88 BRONCHOPULMONARY ASPERGILLOSIS 149 0.0192
89 DISSEMINATED TUBERCULOSIS 49 0.0191
90 ENDOCARDITIS BACTERIAL 15 0.0191
91 ASPERGILLUS INFECTION 125 0.0190
92 MULTIPLE ORGAN DYSFUNCTION SYNDROME 515 0.0182
93 HEPATITIS TOXIC 47 0.0180
94 PSEUDOMEMBRANOUS COLITIS 40 0.0179
95 DRUG DISPENSED TO WRONG PATIENT 17 0.0178
96 INFECTIOUS PLEURAL EFFUSION 27 0.0177
97 PERIPHERAL SENSORY NEUROPATHY 103 0.0176
98 HYPOFIBRINOGENAEMIA 17 0.0171
99 MUCORMYCOSIS 44 0.0169
100 CARDIOPULMONARY FAILURE 66 0.0169
101 BONE MARROW TOXICITY 20 0.0169
102 APLASIA PURE RED CELL 58 0.0168
103 PULMONARY TUBERCULOSIS 72 0.0168
104 SUSPECTED OFF LABEL USE 76 0.0168
105 PANCYTOPENIA 936 0.0167
106 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 91 0.0167
107 RESPIRATORY ALKALOSIS 27 0.0166
108 STAPHYLOCOCCAL BACTERAEMIA 71 0.0163
109 MIXED LIVER INJURY 49 0.0163
110 STENOTROPHOMONAS INFECTION 22 0.0162
111 HYPOPERFUSION 17 0.0162
112 FUNGAEMIA 25 0.0159
113 CLOSTRIDIUM TEST POSITIVE 35 0.0159
114 KLEBSIELLA BACTERAEMIA 15 0.0158
115 HEPATITIS CHOLESTATIC 95 0.0158
116 MYCOBACTERIAL INFECTION 27 0.0157
117 WOUND INFECTION STAPHYLOCOCCAL 27 0.0156
118 ENTEROBACTER INFECTION 26 0.0155
119 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 396 0.0154
120 BLOOD LACTIC ACID INCREASED 81 0.0154
121 HAEMATOTOXICITY 145 0.0152
122 PNEUMONIA FUNGAL 60 0.0152
123 SEPTIC SHOCK 654 0.0150
124 HEPATOTOXICITY 327 0.0147
125 BONE MARROW FAILURE 297 0.0146
126 HYPERSENSITIVITY VASCULITIS 38 0.0145
127 POLYNEUROPATHY 173 0.0144
128 STAPHYLOCOCCAL SEPSIS 71 0.0144
129 BONE MARROW DEPRESSION 14 0.0143
130 METABOLIC ALKALOSIS 23 0.0143
131 CLONUS 39 0.0142
132 PNEUMONIA KLEBSIELLA 26 0.0141
133 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 109 0.0140
134 MEGACOLON 22 0.0140
135 ENDOPHTHALMITIS 84 0.0140
136 CLOSTRIDIUM DIFFICILE COLITIS 147 0.0138
137 EOSINOPHILIA 242 0.0138
138 DRUG CLEARANCE DECREASED 18 0.0138
139 PSEUDOMONAS INFECTION 114 0.0133
140 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 20 0.0130
141 RASH MORBILLIFORM 36 0.0130
142 NORMOCYTIC ANAEMIA 19 0.0129
143 GROIN ABSCESS 15 0.0127
144 ALCOHOL POISONING 34 0.0127
145 HEPATIC CYTOLYSIS 160 0.0125
146 VASCULAR DEVICE INFECTION 56 0.0123
147 STAPHYLOCOCCUS TEST POSITIVE 26 0.0123
148 APLASIA 24 0.0122
149 PERIPHERAL MOTOR NEUROPATHY 17 0.0121
150 CHOLESTATIC LIVER INJURY 27 0.0121
151 DISSEMINATED INTRAVASCULAR COAGULATION 170 0.0121
152 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 60 0.0120
153 ENDOCARDITIS 61 0.0119
154 HEPATITIS FULMINANT 35 0.0118
155 BACTERAEMIA 140 0.0118
156 PNEUMONIA PSEUDOMONAL 18 0.0117
157 CYTOPENIA 143 0.0117
158 INTERVERTEBRAL DISCITIS 22 0.0117
159 MYELOSUPPRESSION 407 0.0113
160 HAEMODYNAMIC INSTABILITY 86 0.0113
161 STAPHYLOCOCCAL INFECTION 370 0.0112
162 BILIRUBIN CONJUGATED INCREASED 26 0.0111
163 EMPYEMA 22 0.0111
164 TOXIC EPIDERMAL NECROLYSIS 167 0.0110
165 SOFT TISSUE INFECTION 20 0.0109
166 NOSOCOMIAL INFECTION 24 0.0109
167 NEUROPATHY PERIPHERAL 1019 0.0107
168 NORMOCHROMIC NORMOCYTIC ANAEMIA 32 0.0106
169 OPTIC NERVE DISORDER 17 0.0106
170 GLOMERULAR FILTRATION RATE ABNORMAL 15 0.0106
171 OPTIC ATROPHY 17 0.0104
172 CANDIDA INFECTION 175 0.0104
173 PLATELET COUNT DECREASED 1088 0.0102
174 HEPATOSPLENOMEGALY 26 0.0101
175 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 96 0.0100
176 HYPERBILIRUBINAEMIA 104 0.0100
177 NEUROPATHY 17 0.0100
178 LONG QT SYNDROME 24 0.0100
179 TORTICOLLIS 21 0.0099
180 RASH MACULO-PAPULAR 219 0.0098
181 WOUND DEHISCENCE 33 0.0098
182 CYSTIC FIBROSIS 54 0.0097
183 COAGULATION TIME PROLONGED 15 0.0097
184 OPHTHALMOPLEGIA 15 0.0095
185 CLOSTRIDIAL INFECTION 32 0.0095
186 DRUG-INDUCED LIVER INJURY 296 0.0094
187 APLASTIC ANAEMIA 49 0.0094
188 BLOOD CULTURE POSITIVE 28 0.0093
189 ANAEMIA 1777 0.0093
190 DISTRIBUTIVE SHOCK 21 0.0093
191 DRUG INTERACTION 1460 0.0092
192 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 69 0.0092
193 NEPHROPATHY TOXIC 103 0.0092
194 DRUG LEVEL BELOW THERAPEUTIC 50 0.0091
195 CANDIDIASIS 36 0.0090
196 HYPOPROTEINAEMIA 17 0.0090
197 CHOLESTASIS 172 0.0089
198 RESPIRATORY ACIDOSIS 35 0.0089
199 RESPIRATORY FAILURE 647 0.0089
200 MULTI-ORGAN FAILURE 153 0.0088
201 DEAFNESS BILATERAL 15 0.0088
202 BLOOD ALBUMIN DECREASED 70 0.0088
203 NEUTROPENIC SEPSIS 63 0.0088
204 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 29 0.0088
205 HEPATITIS ACUTE 57 0.0088
206 ACUTE RESPIRATORY DISTRESS SYNDROME 155 0.0088
207 EXFOLIATIVE RASH 23 0.0087
208 BRAIN HERNIATION 26 0.0087
209 ELECTROLYTE IMBALANCE 101 0.0087
210 LUNG ABSCESS 18 0.0086
211 PROTHROMBIN TIME PROLONGED 51 0.0085
212 HYPOMAGNESAEMIA 118 0.0085
213 HUMAN HERPESVIRUS 6 INFECTION 16 0.0085
214 ORGAN FAILURE 34 0.0084
215 COMPLICATIONS OF TRANSPLANTED KIDNEY 19 0.0084
216 METABOLIC ENCEPHALOPATHY 25 0.0083
217 PNEUMOMEDIASTINUM 15 0.0083
218 DRUG LEVEL ABOVE THERAPEUTIC 38 0.0083
219 HYPERPYREXIA 35 0.0083
220 LYMPHADENITIS 20 0.0083
221 DRUG LEVEL DECREASED 84 0.0082
222 DRUG LEVEL INCREASED 136 0.0082
223 OLIGURIA 51 0.0082
224 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 19 0.0082
225 GLOSSITIS 29 0.0082
226 FIBRIN D DIMER INCREASED 29 0.0082
227 ESCHERICHIA INFECTION 67 0.0081
228 DISORGANISED SPEECH 15 0.0081
229 SUBCUTANEOUS ABSCESS 39 0.0081
230 ANURIA 70 0.0081
231 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 31 0.0081
232 SHOCK HAEMORRHAGIC 66 0.0081
233 ARTHRITIS BACTERIAL 33 0.0080
234 HYPERREFLEXIA 28 0.0080
235 LIVER ABSCESS 26 0.0080
236 TENOSYNOVITIS 22 0.0080
237 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 81 0.0079
238 HISTIOCYTOSIS HAEMATOPHAGIC 23 0.0077
239 CUTANEOUS VASCULITIS 28 0.0077
240 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 20 0.0076
241 MULTI-ORGAN DISORDER 15 0.0076
242 ACUTE RESPIRATORY FAILURE 146 0.0076
243 CHOLECYSTITIS ACUTE 43 0.0076
244 INTRA-ABDOMINAL HAEMORRHAGE 18 0.0076
245 GRANULOCYTE COUNT DECREASED 14 0.0075
246 PLATELET DISORDER 19 0.0075
247 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 20 0.0075
248 TACHYPNOEA 102 0.0075
249 DERMATITIS EXFOLIATIVE GENERALISED 26 0.0075
250 MYOCLONUS 89 0.0075
251 CEREBRAL HAEMATOMA 25 0.0074
252 METABOLIC ACIDOSIS 237 0.0074
253 BACTERIAL SEPSIS 24 0.0074
254 NEUROLOGICAL DECOMPENSATION 17 0.0073
255 DEVICE RELATED INFECTION 113 0.0073
256 HYPOALBUMINAEMIA 57 0.0073
257 HYPERURICAEMIA 30 0.0073
258 TRANSAMINASES INCREASED 162 0.0073
259 NEUTROPENIC COLITIS 15 0.0072
260 ELECTROCARDIOGRAM T WAVE INVERSION 16 0.0072
261 ESCHERICHIA BACTERAEMIA 17 0.0072
262 DRUG ERUPTION 128 0.0072
263 ENTEROCOLITIS 41 0.0071
264 AMYLASE INCREASED 26 0.0070
265 HEPATIC FAILURE 211 0.0070
266 PANCREATITIS NECROTISING 16 0.0070
267 PNEUMOTHORAX 110 0.0069
268 SPUTUM INCREASED 15 0.0069
269 BLOOD DISORDER 55 0.0069
270 TUBULOINTERSTITIAL NEPHRITIS 128 0.0068
271 HYPERAMMONAEMIA 34 0.0068
272 THERAPEUTIC RESPONSE DELAYED 19 0.0068
273 CARDIAC FAILURE ACUTE 45 0.0067
274 COAGULOPATHY 112 0.0067
275 LIVEDO RETICULARIS 14 0.0067
276 SHOCK 154 0.0067
277 LEUKOPENIA 334 0.0067
278 ENCEPHALITIS 46 0.0066
279 HYPERCAPNIA 20 0.0066
280 ABSCESS LIMB 28 0.0066
281 HYPOKALAEMIA 301 0.0065
282 ACUTE MYELOID LEUKAEMIA RECURRENT 14 0.0065
283 CREATININE RENAL CLEARANCE DECREASED 26 0.0065
284 HYPERNATRAEMIA 32 0.0064
285 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 14 0.0064
286 SEPSIS 706 0.0063
287 PNEUMONIA BACTERIAL 58 0.0063
288 AGRANULOCYTOSIS 117 0.0063
289 ACUTE KIDNEY INJURY 962 0.0063
290 THROMBOCYTOSIS 23 0.0063
291 ABDOMINAL RIGIDITY 17 0.0063
292 ABDOMINAL INFECTION 16 0.0063
293 NECROTISING FASCIITIS 22 0.0062
294 LUNG INFILTRATION 55 0.0062
295 DYSPNOEA AT REST 18 0.0062
296 BLOOD CHLORIDE DECREASED 16 0.0062
297 UVEITIS 84 0.0062
298 BRAIN NATRIURETIC PEPTIDE INCREASED 19 0.0062
299 HYPONATRAEMIA 346 0.0061
300 HAEMATOLOGICAL INFECTION 15 0.0061
301 BLOOD CREATININE DECREASED 19 0.0061
302 TOXIC SKIN ERUPTION 61 0.0061
303 ARTHRITIS INFECTIVE 28 0.0060
304 TACHYARRHYTHMIA 15 0.0060
305 PULMONARY HAEMORRHAGE 47 0.0060
306 INTESTINAL ISCHAEMIA 33 0.0060
307 PURPURA 53 0.0060
308 RESPIRATORY DISTRESS 165 0.0060
309 DISTURBANCE IN SOCIAL BEHAVIOUR 14 0.0059
310 BRONCHIECTASIS 40 0.0059
311 TUBERCULIN TEST POSITIVE 15 0.0059
312 TOXIC ENCEPHALOPATHY 30 0.0059
313 NEPHROGENIC ANAEMIA 27 0.0058
314 WRONG PATIENT RECEIVED PRODUCT 17 0.0058
315 BLOOD CREATININE ABNORMAL 20 0.0058
316 GENERALISED OEDEMA 71 0.0057
317 CYTOMEGALOVIRUS INFECTION 95 0.0057
318 HYDROCEPHALUS 31 0.0057
319 HEPARIN-INDUCED THROMBOCYTOPENIA 28 0.0057
320 RENAL IMPAIRMENT 476 0.0057
321 ACIDOSIS 43 0.0056
322 GRAFT VERSUS HOST DISEASE 40 0.0056
323 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 304 0.0055
324 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 28 0.0055
325 OSTEOMYELITIS 100 0.0055
326 PANCREATITIS ACUTE 124 0.0055
327 BLOOD BILIRUBIN INCREASED 149 0.0055
328 INTERNATIONAL NORMALISED RATIO INCREASED 157 0.0055
329 ACUTE HEPATIC FAILURE 75 0.0055
330 ENCEPHALOPATHY 134 0.0055
331 AORTIC ARTERIOSCLEROSIS 14 0.0054
332 CYTOLYTIC HEPATITIS 18 0.0054
333 ATELECTASIS 52 0.0054
334 JAUNDICE CHOLESTATIC 19 0.0054
335 EXTRAVASATION 22 0.0053
336 HYPOGAMMAGLOBULINAEMIA 35 0.0053
337 PAPILLOEDEMA 24 0.0053
338 HIV INFECTION 16 0.0053
339 HAEMOPTYSIS 148 0.0053
340 HYPOGLYCAEMIA 256 0.0053
341 HEPATITIS 135 0.0053
342 LEUKOCYTOSIS 95 0.0052
343 INTRAOCULAR PRESSURE INCREASED 67 0.0052
344 MENINGITIS 35 0.0052
345 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 17 0.0052
346 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 31 0.0052
347 TORSADE DE POINTES 41 0.0052
348 DECUBITUS ULCER 42 0.0051
349 HEPATIC ENCEPHALOPATHY 48 0.0051
350 NEUROTOXICITY 90 0.0051
351 HALLUCINATION, VISUAL 108 0.0051
352 STATUS EPILEPTICUS 57 0.0050
353 HAEMOLYTIC ANAEMIA 45 0.0050
354 ORAL CANDIDIASIS 66 0.0050
355 LUNG CONSOLIDATION 14 0.0050
356 DEAFNESS 130 0.0050
357 PARTIAL SEIZURES 26 0.0050
358 CYTOMEGALOVIRUS VIRAEMIA 22 0.0049
359 HEPATOCELLULAR INJURY 69 0.0049
360 CLOSTRIDIUM DIFFICILE INFECTION 106 0.0049
361 NECROSIS 27 0.0048
362 BLOOD URIC ACID INCREASED 28 0.0048
363 TREATMENT FAILURE 401 0.0048
364 BLOOD UREA INCREASED 81 0.0048
365 ASPARTATE AMINOTRANSFERASE INCREASED 255 0.0048
366 HEPATIC FUNCTION ABNORMAL 179 0.0048
367 HAEMORRHAGE SUBCUTANEOUS 17 0.0048
368 INCORRECT PRODUCT ADMINISTRATION DURATION 103 0.0047
369 DELIRIUM 164 0.0047
370 HYPERTHERMIA 36 0.0047
371 PURULENT DISCHARGE 20 0.0047
372 INTRACRANIAL PRESSURE INCREASED 26 0.0047
373 ALTERED STATE OF CONSCIOUSNESS 101 0.0047
374 VENOOCCLUSIVE LIVER DISEASE 23 0.0047
375 TRANSPLANT REJECTION 37 0.0046
376 ATRIOVENTRICULAR BLOCK SECOND DEGREE 14 0.0046
377 SINUS TACHYCARDIA 65 0.0046
378 URINE OUTPUT DECREASED 40 0.0046
379 PULMONARY FUNCTION TEST DECREASED 20 0.0046
380 HAEMOGLOBIN DECREASED 467 0.0045
381 PROTEIN TOTAL DECREASED 17 0.0045
382 HYPOCALCAEMIA 85 0.0045
383 ESCHERICHIA URINARY TRACT INFECTION 19 0.0045
384 STEVENS-JOHNSON SYNDROME 99 0.0044
385 BK VIRUS INFECTION 15 0.0044
386 EOSINOPHIL COUNT INCREASED 37 0.0044
387 VISUAL ACUITY REDUCED 147 0.0044
388 BRONCHOSPASM 63 0.0044
389 MYOPATHY 38 0.0044
390 DERMATITIS EXFOLIATIVE 22 0.0044
391 HEPATIC LESION 19 0.0044
392 HYPOVOLAEMIC SHOCK 21 0.0044
393 ALANINE AMINOTRANSFERASE INCREASED 269 0.0044
394 BLOOD CREATINE PHOSPHOKINASE INCREASED 126 0.0044
395 LEG AMPUTATION 18 0.0044
396 RENAL FAILURE ACUTE 184 0.0043
397 BLOOD CREATININE INCREASED 283 0.0043
398 LYMPHOPENIA 61 0.0043
399 PETECHIAE 45 0.0043
400 POSTOPERATIVE WOUND INFECTION 29 0.0043
401 MALNUTRITION 48 0.0043
402 BACTERIAL INFECTION 80 0.0043
403 CACHEXIA 22 0.0043
404 HYPERKALAEMIA 149 0.0042
405 FUNGAL INFECTION 141 0.0042
406 MENTAL STATUS CHANGES 117 0.0042
407 FUNGAL SKIN INFECTION 17 0.0042
408 HYPOXIA 147 0.0042
409 GLOMERULAR FILTRATION RATE DECREASED 51 0.0041
410 UROSEPSIS 38 0.0041
411 GENERALISED TONIC-CLONIC SEIZURE 68 0.0041
412 RENAL TUBULAR NECROSIS 40 0.0041
413 HALLUCINATIONS, MIXED 17 0.0040
414 SUBARACHNOID HAEMORRHAGE 41 0.0040
415 ABSCESS 64 0.0040
416 DERMATITIS BULLOUS 29 0.0040
417 HAEMATOCRIT DECREASED 79 0.0040
418 RENAL FAILURE 526 0.0040
419 RHABDOMYOLYSIS 165 0.0040
420 STREPTOCOCCAL INFECTION 22 0.0039
421 VENTRICULAR EXTRASYSTOLES 41 0.0039
422 MUCOSAL INFLAMMATION 103 0.0039
423 ACUTE GRAFT VERSUS HOST DISEASE 18 0.0039
424 HAEMORRHAGIC DIATHESIS 14 0.0039
425 BLOOD SODIUM DECREASED 74 0.0039
426 ISCHAEMIA 18 0.0039
427 CYTOKINE RELEASE SYNDROME 78 0.0039
428 EPSTEIN-BARR VIRUS INFECTION 24 0.0038
429 ABDOMINAL TENDERNESS 19 0.0038
430 END STAGE RENAL DISEASE 69 0.0038
431 CIRCULATORY COLLAPSE 63 0.0037
432 PULMONARY MASS 55 0.0037
433 MUSCLE RIGIDITY 44 0.0037
434 C-REACTIVE PROTEIN INCREASED 133 0.0037
435 ECCHYMOSIS 25 0.0036
436 RED BLOOD CELL COUNT DECREASED 104 0.0036
437 ABDOMINAL ABSCESS 16 0.0036
438 CELLULITIS 182 0.0036
439 PULSELESS ELECTRICAL ACTIVITY 15 0.0036
440 SPUTUM DISCOLOURED 34 0.0036
441 LIVER FUNCTION TEST ABNORMAL 104 0.0036
442 CONCOMITANT DISEASE AGGRAVATED 22 0.0036
443 BRAIN OEDEMA 45 0.0036
444 ASPIRATION 39 0.0036
445 MOUTH HAEMORRHAGE 26 0.0035
446 FEBRILE BONE MARROW APLASIA 15 0.0035
447 HUMERUS FRACTURE 17 0.0035
448 LIPASE INCREASED 27 0.0035
449 PANCREATITIS 186 0.0035
450 RENAL FAILURE CHRONIC 27 0.0035
451 LEFT VENTRICULAR HYPERTROPHY 15 0.0035
452 PNEUMOCYSTIS JIROVECII PNEUMONIA 35 0.0035
453 GANGRENE 21 0.0035
454 NEUTROPHIL COUNT DECREASED 142 0.0035
455 CARDIOTOXICITY 31 0.0035
456 NEUTROPENIA 472 0.0035
457 PLEURAL EFFUSION 211 0.0035
458 NEUROLEPTIC MALIGNANT SYNDROME 41 0.0035
459 PLATELET COUNT INCREASED 45 0.0034
460 UPPER GASTROINTESTINAL HAEMORRHAGE 58 0.0034
461 THERAPY NON-RESPONDER 154 0.0034
462 LIVER INJURY 84 0.0034
463 ACUTE PULMONARY OEDEMA 19 0.0034
464 BLOOD CALCIUM DECREASED 38 0.0034
465 TENDON DISORDER 22 0.0034
466 WHITE BLOOD CELL COUNT INCREASED 129 0.0034
467 BLOOD MAGNESIUM DECREASED 29 0.0034
468 BLOOD ALKALINE PHOSPHATASE INCREASED 83 0.0033
469 DERMATITIS ALLERGIC 42 0.0033
470 VENTRICULAR TACHYCARDIA 55 0.0033
471 PRODUCT PRESCRIBING ISSUE 72 0.0033
472 THROMBOTIC MICROANGIOPATHY 32 0.0033
473 LUNG INFECTION 51 0.0033
474 IMMUNE THROMBOCYTOPENIA 15 0.0033
475 RALES 19 0.0033
476 PAPULE 23 0.0033
477 BLOOD POTASSIUM INCREASED 53 0.0033
478 FEBRILE NEUTROPENIA 216 0.0033
479 HYPOPHOSPHATAEMIA 24 0.0032
480 PYELONEPHRITIS 28 0.0032
481 INFLAMMATORY MARKER INCREASED 16 0.0032
482 GASTROINTESTINAL DISORDER 289 0.0032
483 COVID-19 PNEUMONIA 38 0.0032
484 HAEMODIALYSIS 27 0.0032
485 NERVOUS SYSTEM DISORDER 100 0.0032
486 MOUTH ULCERATION 67 0.0032
487 DRUG TOXICITY 43 0.0032
488 ILEUS PARALYTIC 14 0.0031
489 CARDIOGENIC SHOCK 45 0.0031
490 PSYCHOTIC DISORDER 91 0.0031
491 TOXICITY TO VARIOUS AGENTS 519 0.0031
492 PERICARDIAL EFFUSION 71 0.0031
493 TUMOUR LYSIS SYNDROME 27 0.0031
494 GAMMA-GLUTAMYLTRANSFERASE INCREASED 68 0.0031
495 VISUAL FIELD DEFECT 22 0.0030
496 DRUG INTOLERANCE 294 0.0030
497 BREATH SOUNDS ABNORMAL 15 0.0030
498 SERUM FERRITIN INCREASED 16 0.0030
499 ORGANISING PNEUMONIA 15 0.0030
500 ACUTE CORONARY SYNDROME 25 0.0030
501 PYREXIA 1039 0.0030
502 OFF LABEL USE 2626 0.0030
503 BODY TEMPERATURE INCREASED 61 0.0030
504 CORONARY ARTERY STENOSIS 15 0.0030
505 GASTROENTERITIS 43 0.0029
506 GASTROINTESTINAL HAEMORRHAGE 244 0.0029
507 KIDNEY TRANSPLANT REJECTION 14 0.0029
508 ASCITES 85 0.0029
509 HYPERTENSIVE CRISIS 32 0.0029
510 ARTERIOSCLEROSIS CORONARY ARTERY 19 0.0029
511 PULMONARY ALVEOLAR HAEMORRHAGE 16 0.0028
512 HEPATOMEGALY 28 0.0028
513 HAEMOLYSIS 22 0.0028
514 PRODUCT USE IN UNAPPROVED INDICATION 706 0.0028
515 CARDIAC ARREST 234 0.0028
516 HYPERTONIA 16 0.0028
517 VENTRICULAR FIBRILLATION 31 0.0028
518 VISUAL DISTURBANCE 16 0.0028
519 HALLUCINATION 210 0.0028
520 MELAENA 61 0.0028
521 CONFUSIONAL STATE 447 0.0028
522 TONGUE DISORDER 20 0.0028
523 ACUTE MYELOID LEUKAEMIA 43 0.0028
524 JAUNDICE 74 0.0027
525 WOUND INFECTION 30 0.0027
526 CONDITION AGGRAVATED 830 0.0027
527 CARDIAC FAILURE 219 0.0027
528 HAEMATURIA 93 0.0027
529 RIGHT VENTRICULAR FAILURE 19 0.0027
530 WHITE BLOOD CELL COUNT DECREASED 291 0.0027
531 TACHYCARDIA 238 0.0027
532 GENERAL PHYSICAL CONDITION ABNORMAL 18 0.0027
533 NEUTROPHILIA 15 0.0026
534 NEUTROPHIL COUNT INCREASED 27 0.0026
535 CARDIO-RESPIRATORY ARREST 109 0.0026
536 HYPOTONIA 26 0.0026
537 BRADYPHRENIA 17 0.0026
538 HEMIPARESIS 44 0.0026
539 EPILEPSY 79 0.0026
540 HYPOTENSION 518 0.0026
541 FACIAL PARALYSIS 22 0.0026
542 MYDRIASIS 33 0.0026
543 HYPOTHERMIA 26 0.0026
544 POLYURIA 21 0.0026
545 OESOPHAGITIS 28 0.0026
546 DEPRESSED LEVEL OF CONSCIOUSNESS 101 0.0026
547 HEPATIC ENZYME INCREASED 174 0.0025
548 ARTERIOSCLEROSIS 24 0.0025
549 SKIN MASS 17 0.0025
550 DISEASE RECURRENCE 121 0.0025
551 PLEURISY 15 0.0025
552 CHOLECYSTITIS 30 0.0025
553 WRONG PRODUCT ADMINISTERED 17 0.0025
554 BLOOD POTASSIUM DECREASED 75 0.0025
555 IMMUNOSUPPRESSION 22 0.0025
556 INTENTIONAL PRODUCT USE ISSUE 218 0.0025
557 HAEMOGLOBIN ABNORMAL 16 0.0025
558 RASH PUSTULAR 18 0.0025
559 DIFFUSE LARGE B-CELL LYMPHOMA 19 0.0025
560 VOMITING 1158 0.0025
561 BLOOD LACTATE DEHYDROGENASE INCREASED 39 0.0025
562 HAEMATEMESIS 62 0.0024
563 PIGMENTATION DISORDER 15 0.0024
564 GENERAL PHYSICAL HEALTH DETERIORATION 280 0.0024
565 RESPIRATORY SYNCYTIAL VIRUS INFECTION 21 0.0024
566 PRODUCTIVE COUGH 115 0.0024
567 ORAL HERPES 47 0.0024
568 RASH ERYTHEMATOUS 115 0.0024
569 PULMONARY TOXICITY 17 0.0024
570 VASCULITIS 28 0.0024
571 SUPRAVENTRICULAR TACHYCARDIA 23 0.0024
572 CEREBRAL HAEMORRHAGE 86 0.0024
573 HYPOVOLAEMIA 14 0.0024
574 TRICUSPID VALVE INCOMPETENCE 19 0.0024
575 ARRHYTHMIA 113 0.0024
576 GRAND MAL CONVULSION 22 0.0024
577 SINUS BRADYCARDIA 23 0.0024
578 HYPOACUSIS 102 0.0024
579 CARDIOMYOPATHY 35 0.0024
580 RESPIRATORY RATE INCREASED 21 0.0024
581 SUDDEN DEATH 25 0.0024
582 SKIN HYPERPIGMENTATION 20 0.0023
583 LOWER GASTROINTESTINAL HAEMORRHAGE 17 0.0023
584 PNEUMONIA 741 0.0023
585 PNEUMONIA ASPIRATION 57 0.0023
586 GASTRITIS 60 0.0023
587 AGITATION 167 0.0023
588 INFECTION 329 0.0023
589 DISORIENTATION 90 0.0023
590 PERITONITIS 47 0.0023
591 CORONAVIRUS INFECTION 15 0.0023
592 TINNITUS 104 0.0023
593 ANOREXIA 29 0.0022
594 NEPHROPATHY 21 0.0022
595 HAEMATOMA 58 0.0022
596 CONVULSION 128 0.0022
597 SUBDURAL HAEMATOMA 32 0.0022
598 TREATMENT NONCOMPLIANCE 122 0.0022
599 FAECES DISCOLOURED 48 0.0022
600 MYOCARDIAL ISCHAEMIA 25 0.0022
601 HYPOPHAGIA 56 0.0022
602 SKIN LESION 60 0.0022
603 PNEUMONITIS 59 0.0022
604 DECREASED APPETITE 503 0.0022
605 RASH GENERALISED 56 0.0022
606 HEPATITIS C 26 0.0022
607 RESPIRATORY TRACT INFECTION 56 0.0021
608 SKIN INFECTION 24 0.0021
609 PREMATURE DELIVERY 34 0.0021
610 TEMPERATURE INTOLERANCE 22 0.0021
611 CONTRAINDICATED PRODUCT ADMINISTERED 64 0.0021
612 APPETITE DISORDER 14 0.0021
613 RESTLESSNESS 77 0.0021
614 FACE OEDEMA 35 0.0021
615 RESPIRATORY DISORDER 62 0.0021
616 BLINDNESS 84 0.0021
617 COMA 98 0.0021
618 LOCALISED INFECTION 49 0.0020
619 LYMPHOEDEMA 14 0.0020
620 LOW BIRTH WEIGHT BABY 16 0.0020
621 OEDEMA 109 0.0020
622 UNRESPONSIVE TO STIMULI 51 0.0020
623 HYPOTHYROIDISM 63 0.0020
624 PULMONARY OEDEMA 88 0.0020
625 MITRAL VALVE INCOMPETENCE 22 0.0019
626 LYMPHOCYTE COUNT DECREASED 34 0.0019
627 PULMONARY HYPERTENSION 40 0.0019
628 DISEASE PROGRESSION 227 0.0019
629 RENAL CYST 15 0.0019
630 OXYGEN SATURATION DECREASED 106 0.0019
631 RENAL INJURY 56 0.0019
632 DYSGEUSIA 140 0.0019
633 PALLOR 51 0.0019
634 ORAL DISCOMFORT 26 0.0019
635 HYDRONEPHROSIS 14 0.0019
636 SENSORY LOSS 15 0.0019
637 HYPERCALCAEMIA 23 0.0019
638 NEURALGIA 45 0.0018
639 IRON DEFICIENCY ANAEMIA 17 0.0018
640 NAUSEA 1450 0.0018
641 TENDERNESS 19 0.0018
642 INTERSTITIAL LUNG DISEASE 88 0.0018
643 FLANK PAIN 17 0.0018
644 HEPATIC CIRRHOSIS 34 0.0018
645 EMBOLISM 15 0.0018
646 CHRONIC KIDNEY DISEASE 137 0.0018
647 EYE PAIN 101 0.0018
648 PERITONITIS BACTERIAL 18 0.0018
649 LIVER FUNCTION TEST INCREASED 38 0.0018
650 DYSPHAGIA 165 0.0017
651 PRODUCT USE ISSUE 326 0.0017
652 THERAPY PARTIAL RESPONDER 27 0.0017
653 RED BLOOD CELL SEDIMENTATION RATE INCREASED 19 0.0017
654 HYPERAESTHESIA 14 0.0017
655 SKIN REACTION 24 0.0017
656 PHOTOPHOBIA 32 0.0017
657 FULL BLOOD COUNT DECREASED 34 0.0017
658 NODULE 22 0.0017
659 SEIZURE 194 0.0017
660 DIARRHOEA 1084 0.0017
661 BRADYCARDIA 89 0.0017
662 HYPOAESTHESIA 250 0.0017
663 PULMONARY CONGESTION 22 0.0017
664 SKIN ULCER 43 0.0017
665 VERTIGO 101 0.0017
666 DYSPNOEA EXERTIONAL 62 0.0016
667 NO THERAPEUTIC RESPONSE 20 0.0016
668 CHROMATURIA 37 0.0016
669 DIALYSIS 23 0.0016
670 CARDIAC MURMUR 14 0.0016
671 POST PROCEDURAL COMPLICATION 31 0.0016
672 DRUG INEFFECTIVE 2126 0.0016
673 ABDOMINAL PAIN 375 0.0016
674 ILEUS 20 0.0016
675 APPENDICITIS 15 0.0016
676 INTESTINAL PERFORATION 18 0.0016
677 ATAXIA 19 0.0016
678 BRAIN INJURY 16 0.0016
679 HYPERGLYCAEMIA 58 0.0016
680 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 14 0.0016
681 HALLUCINATION, AUDITORY 25 0.0016
682 LUNG DISORDER 77 0.0016
683 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 46 0.0016
684 GLOSSODYNIA 35 0.0016
685 ORAL PAIN 35 0.0016
686 PARAESTHESIA 245 0.0016
687 ANAL INCONTINENCE 14 0.0016
688 LIVER DISORDER 69 0.0016
689 ASTHENIA 583 0.0015
690 RESPIRATORY DEPRESSION 19 0.0015
691 BLOOD PRESSURE DECREASED 103 0.0015
692 HIATUS HERNIA 20 0.0015
693 VISUAL IMPAIRMENT 191 0.0015
694 GINGIVAL BLEEDING 21 0.0015
695 SWOLLEN TONGUE 48 0.0015
696 SPLENOMEGALY 18 0.0015
697 PERIPHERAL COLDNESS 21 0.0015
698 MYELODYSPLASTIC SYNDROME 22 0.0015
699 RECTAL HAEMORRHAGE 65 0.0015
700 ISCHAEMIC STROKE 27 0.0015
701 PSYCHOMOTOR HYPERACTIVITY 25 0.0015
702 EATING DISORDER 32 0.0015
703 ERYTHEMA MULTIFORME 14 0.0015
704 BLOOD TEST ABNORMAL 21 0.0015
705 JOINT RANGE OF MOTION DECREASED 20 0.0015
706 DERMATITIS 31 0.0015
707 LIP SWELLING 49 0.0015
708 PARALYSIS 21 0.0015
709 OEDEMA PERIPHERAL 178 0.0015
710 LETHARGY 84 0.0015
711 VISION BLURRED 199 0.0014
712 TREMOR 240 0.0014
713 FLUID OVERLOAD 21 0.0014
714 CHILLS 169 0.0014
715 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
716 DEHYDRATION 190 0.0014
717 ATRIAL FIBRILLATION 138 0.0014
718 EJECTION FRACTION DECREASED 22 0.0014
719 HAEMORRHAGE INTRACRANIAL 21 0.0014
720 DERMATITIS CONTACT 16 0.0014
721 HEPATIC STEATOSIS 26 0.0014
722 CEREBRAL INFARCTION 34 0.0014
723 GASTRIC HAEMORRHAGE 16 0.0014
724 DYSPNOEA 778 0.0014
725 GASTRIC ULCER 26 0.0014
726 COORDINATION ABNORMAL 19 0.0014
727 LYMPHADENOPATHY 48 0.0014
728 RASH 591 0.0014
729 OBSTRUCTIVE AIRWAYS DISORDER 15 0.0013
730 UPPER RESPIRATORY TRACT INFECTION 62 0.0013
731 LOWER RESPIRATORY TRACT INFECTION 61 0.0013
732 CYANOSIS 21 0.0013
733 MENTAL DISORDER 58 0.0013
734 HYPOAESTHESIA ORAL 20 0.0013
735 INFLAMMATION 68 0.0013
736 DIPLOPIA 34 0.0013
737 WEIGHT DECREASED 364 0.0013
738 SMALL INTESTINAL OBSTRUCTION 16 0.0013
739 HYPERTENSION 275 0.0013
740 EYELID OEDEMA 15 0.0013
741 AGEUSIA 32 0.0013
742 DRY MOUTH 104 0.0013
743 DEEP VEIN THROMBOSIS 83 0.0013
744 HAEMORRHAGE 133 0.0013
745 PHOTOSENSITIVITY REACTION 21 0.0013
746 SKIN DISCOLOURATION 58 0.0013
747 EPISTAXIS 94 0.0013
748 ANHEDONIA 33 0.0013
749 METASTASES TO LIVER 22 0.0013
750 SCAR 21 0.0012
751 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 64 0.0012
752 PULMONARY EMBOLISM 115 0.0012
753 PROTEINURIA 23 0.0012
754 PULMONARY FIBROSIS 23 0.0012
755 ERYTHEMA 246 0.0012
756 DYSURIA 44 0.0012
757 ECONOMIC PROBLEM 18 0.0012
758 COLITIS 45 0.0012
759 RENAL DISORDER 55 0.0012
760 HAEMATOCHEZIA 65 0.0012
761 MUSCLE TWITCHING 27 0.0012
762 CARDIAC FAILURE CONGESTIVE 94 0.0012
763 PHARYNGEAL OEDEMA 18 0.0012
764 ABDOMINAL DISTENSION 122 0.0012
765 HYPERHIDROSIS 150 0.0012
766 TENDONITIS 18 0.0012
767 HEART RATE INCREASED 115 0.0012
768 PARANOIA 20 0.0012
769 LOSS OF CONSCIOUSNESS 148 0.0012
770 MANIA 19 0.0012
771 WOUND 32 0.0011
772 EXPOSURE DURING PREGNANCY 71 0.0011
773 BEDRIDDEN 15 0.0011
774 INTESTINAL OBSTRUCTION 43 0.0011
775 BLISTER 64 0.0011
776 CARDIOMEGALY 14 0.0011
777 PRODUCT ADMINISTRATION ERROR 23 0.0011
778 MEDICATION ERROR 63 0.0011
779 URINARY TRACT INFECTION 193 0.0011
780 ANAPHYLACTIC REACTION 62 0.0011
781 DYSPEPSIA 110 0.0011
782 HYPERSENSITIVITY 206 0.0011
783 FOETAL EXPOSURE DURING PREGNANCY 90 0.0011
784 BLOOD PRESSURE ABNORMAL 22 0.0011
785 PULMONARY ARTERIAL HYPERTENSION 16 0.0011
786 INCORRECT DRUG ADMINISTRATION DURATION 31 0.0011
787 PREMATURE BABY 33 0.0011
788 STOMATITIS 66 0.0011
789 ANAPHYLACTIC SHOCK 28 0.0011
790 TASTE DISORDER 22 0.0011
791 PALPITATIONS 127 0.0011
792 HEART RATE DECREASED 38 0.0011
793 CHEST DISCOMFORT 110 0.0011
794 ABDOMINAL DISCOMFORT 179 0.0011
795 OSTEOPENIA 16 0.0011
796 FREQUENT BOWEL MOVEMENTS 28 0.0010
797 RETCHING 22 0.0010
798 SEDATION 27 0.0010
799 EAR PAIN 20 0.0010
800 IMPAIRED GASTRIC EMPTYING 14 0.0010
801 POOR QUALITY SLEEP 22 0.0010
802 SKIN EXFOLIATION 86 0.0010
803 PERICARDITIS 17 0.0010
804 PRODUCT DISPENSING ERROR 22 0.0010
805 COVID-19 176 0.0010
806 SKIN DISORDER 33 0.0010
807 DYSARTHRIA 37 0.0010
808 HYPERTHYROIDISM 14 0.0010
809 FEAR 26 0.0010
810 HYPOKINESIA 14 0.0010
811 DIABETES MELLITUS 73 0.0010
812 DEATH 823 0.0010
813 URTICARIA 160 0.0010
814 ACUTE MYOCARDIAL INFARCTION 28 0.0009
815 ABNORMAL BEHAVIOUR 37 0.0009
816 HEART RATE IRREGULAR 21 0.0009
817 PRURITUS GENERALISED 20 0.0009
818 RASH PRURITIC 50 0.0009
819 COUGH 258 0.0009
820 AGGRESSION 46 0.0009
821 CONSTIPATION 198 0.0009
822 LYMPHOMA 14 0.0009
823 PRODUCT PRESCRIBING ERROR 21 0.0009
824 BLOOD PRESSURE INCREASED 133 0.0009
825 BURNING SENSATION 61 0.0009
826 MENTAL IMPAIRMENT 21 0.0009
827 CONJUNCTIVITIS 16 0.0009
828 LOCAL SWELLING 15 0.0009
829 ABDOMINAL PAIN UPPER 177 0.0009
830 ANGIOEDEMA 38 0.0009
831 CHOLELITHIASIS 28 0.0009
832 CHEST PAIN 158 0.0009
833 COLD SWEAT 15 0.0009
834 DIZZINESS 419 0.0008
835 RASH MACULAR 29 0.0008
836 ADVERSE EVENT 76 0.0008
837 BONE DISORDER 15 0.0008
838 MALAISE 361 0.0008
839 DYSPHONIA 48 0.0008
840 HAEMORRHOIDS 16 0.0008
841 DEPRESSION 186 0.0008
842 PAIN IN JAW 23 0.0008
843 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
844 NEPHROLITHIASIS 37 0.0008
845 MUSCULAR WEAKNESS 91 0.0008
846 SYNCOPE 80 0.0008
847 SLEEP DISORDER 56 0.0008
848 CYSTITIS 25 0.0008
849 PRURITUS 300 0.0008
850 GOUT 14 0.0008
851 URINARY RETENTION 26 0.0008
852 ANXIETY 221 0.0008
853 BRONCHITIS 56 0.0008
854 SOMNOLENCE 152 0.0008
855 OSTEOARTHRITIS 32 0.0008
856 BALANCE DISORDER 65 0.0008
857 VIRAL INFECTION 25 0.0008
858 ADVERSE DRUG REACTION 67 0.0007
859 LABORATORY TEST ABNORMAL 22 0.0007
860 DYSKINESIA 30 0.0007
861 APHASIA 22 0.0007
862 CORONARY ARTERY DISEASE 22 0.0007
863 GAIT DISTURBANCE 139 0.0007
864 SWELLING FACE 47 0.0007
865 FEELING COLD 20 0.0007
866 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 51 0.0007
867 HERPES ZOSTER 41 0.0007
868 KIDNEY INFECTION 14 0.0007
869 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 34 0.0007
870 MATERNAL EXPOSURE DURING PREGNANCY 62 0.0007
871 EXPIRED PRODUCT ADMINISTERED 23 0.0007
872 SWELLING 64 0.0007
873 MYALGIA 115 0.0007
874 SYSTEMIC LUPUS ERYTHEMATOSUS 24 0.0007
875 CARDIOVASCULAR DISORDER 17 0.0007
876 ECZEMA 35 0.0007
877 BLOOD GLUCOSE DECREASED 32 0.0007
878 INSOMNIA 176 0.0007
879 PRESYNCOPE 16 0.0007
880 WHEEZING 39 0.0007
881 MOVEMENT DISORDER 21 0.0007
882 IRRITABILITY 39 0.0006
883 ARTHRALGIA 269 0.0006
884 EXTRAPYRAMIDAL DISORDER 16 0.0006
885 OSTEONECROSIS 21 0.0006
886 EAR INFECTION 17 0.0006
887 GASTROOESOPHAGEAL REFLUX DISEASE 51 0.0006
888 PERIPHERAL SWELLING 97 0.0006
889 ANGINA PECTORIS 18 0.0006
890 INFLUENZA 70 0.0006
891 HEADACHE 393 0.0006
892 SPEECH DISORDER 32 0.0006
893 ABASIA 15 0.0006
894 OROPHARYNGEAL PAIN 56 0.0006
895 COGNITIVE DISORDER 28 0.0006
896 HOSPITALISATION 91 0.0006
897 MOOD ALTERED 16 0.0006
898 EMOTIONAL DISORDER 18 0.0006
899 BLOOD PRESSURE FLUCTUATION 14 0.0006
900 DRY EYE 29 0.0006
901 INFUSION RELATED REACTION 38 0.0006
902 HYPERSOMNIA 16 0.0006
903 PANCREATIC CARCINOMA 16 0.0006
904 AMNESIA 36 0.0006
905 POLLAKIURIA 23 0.0006
906 FLUID RETENTION 28 0.0005
907 CRYING 20 0.0005
908 LIMB DISCOMFORT 17 0.0005
909 NIGHTMARE 19 0.0005
910 IMPAIRED HEALING 18 0.0005
911 EYE DISORDER 18 0.0005
912 ARTHRITIS 43 0.0005
913 ERECTILE DYSFUNCTION 14 0.0005
914 RESPIRATORY ARREST 15 0.0005
915 UNEVALUABLE EVENT 41 0.0005
916 FALL 180 0.0005
917 PAIN IN EXTREMITY 159 0.0005
918 OSTEOPOROSIS 22 0.0005
919 THROMBOSIS 43 0.0005
920 BACK PAIN 122 0.0005
921 MYOCARDIAL INFARCTION 90 0.0005
922 LIMB INJURY 14 0.0005
923 PLASMA CELL MYELOMA 20 0.0005
924 INJURY 36 0.0005
925 ASTHMA 57 0.0005
926 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
927 CATARACT 30 0.0005
928 MUSCULOSKELETAL STIFFNESS 44 0.0005
929 OVERDOSE 108 0.0005
930 SINUSITIS 51 0.0005
931 FATIGUE 387 0.0005
932 THERAPEUTIC RESPONSE DECREASED 30 0.0005
933 JOINT SWELLING 59 0.0005
934 DRUG ADMINISTRATION ERROR 15 0.0005
935 EYE SWELLING 18 0.0005
936 MOOD SWINGS 15 0.0005
937 THROAT IRRITATION 21 0.0005
938 NIGHT SWEATS 15 0.0005
939 SUICIDE ATTEMPT 28 0.0005
940 FLATULENCE 26 0.0005
941 MUSCLE SPASMS 84 0.0005
942 CONTUSION 44 0.0005
943 INTENTIONAL PRODUCT MISUSE 40 0.0005
944 RHINORRHOEA 29 0.0004
945 CEREBROVASCULAR ACCIDENT 76 0.0004
946 THERAPY INTERRUPTED 32 0.0004
947 NECK PAIN 25 0.0004
948 ILLNESS 46 0.0004
949 BLOOD GLUCOSE INCREASED 84 0.0004
950 ILL-DEFINED DISORDER 27 0.0004
951 DISCOMFORT 27 0.0004
952 GASTRIC DISORDER 15 0.0004
953 FEELING ABNORMAL 102 0.0004
954 ABORTION SPONTANEOUS 17 0.0004
955 MALIGNANT NEOPLASM PROGRESSION 43 0.0004
956 WEIGHT INCREASED 94 0.0004
957 PAIN 257 0.0004
958 MIGRAINE 39 0.0004
959 FEELING HOT 25 0.0004
960 MUSCULOSKELETAL PAIN 21 0.0004
961 HOT FLUSH 30 0.0004
962 CARDIAC DISORDER 37 0.0004
963 BONE PAIN 23 0.0004
964 EMOTIONAL DISTRESS 47 0.0004
965 ALOPECIA 76 0.0004
966 DRUG EFFECT INCOMPLETE 14 0.0004
967 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
968 UNDERDOSE 27 0.0004
969 MOBILITY DECREASED 26 0.0004
970 FLUSHING 35 0.0003
971 SUICIDAL IDEATION 31 0.0003
972 NERVOUSNESS 17 0.0003
973 COMPLETED SUICIDE 27 0.0003
974 DEPRESSED MOOD 17 0.0003
975 DRUG WITHDRAWAL SYNDROME 28 0.0003
976 PRODUCT DOSE OMISSION 20 0.0003
977 NEOPLASM MALIGNANT 20 0.0003
978 DISTURBANCE IN ATTENTION 16 0.0003
979 INFLUENZA LIKE ILLNESS 24 0.0003
980 SURGERY 17 0.0003
981 ARTHROPATHY 15 0.0003
982 MEMORY IMPAIRMENT 37 0.0003
983 PRODUCT STORAGE ERROR 22 0.0003
984 RHEUMATOID ARTHRITIS 28 0.0002
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
986 NO ADVERSE EVENT 42 0.0002
987 ACNE 17 0.0002
988 PRODUCT DOSE OMISSION ISSUE 62 0.0002
989 DRY SKIN 24 0.0002
990 DRUG DOSE OMISSION 29 0.0002
991 INCORRECT DOSE ADMINISTERED 40 0.0002
992 NASOPHARYNGITIS 29 0.0002
993 PRODUCT QUALITY ISSUE 21 0.0002
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
995 INJECTION SITE PAIN 22 0.0001